Triple Therapy More Cost-Effective Than Biologics for Second-Line RA Treatment
Not many rheumatoid arthritis (RA) patients are put on so-called triple therapy when their initial methotrexate treatment begins to wane in effectiveness. A recent study suggests they should be, demonstrating that the combination, as a second-line treatment to a biologic is comparable in effectiveness. Here are the details.